CGY Stock Analysis: Calian Technologies | TO
Aerospace & Defense | TO, Canada | Market Cap: 1.029m CAD | 12M Return: 65.3% | CA12989J1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.34M
EPS Trend: 58.4%
Qual. Beats: 2
Rev. Trend: 94.7%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Calian Group Ltd. is a Canada-based provider of business services and technology solutions, serving customers in Canada and internationally. Its four segments-Advanced Technologies, Health, Learning, and IT and Cyber Solutions-cover areas including satellite communications, cybersecurity, healthcare, workforce training, engineering, and emergency preparedness.
The company serves public- and private-sector industries such as defense, government, transportation, energy, and manufacturing. Its diversified model combines specialized products with managed services, consulting, training, and engineering support.
- Canadian defense spending and satellite demand expand Advanced Technologies backlog
- Health contract renewals and service mix drive segment revenue and margins
- Acquisition integration and debt reduction shape cash flow and capital returns
| Net Income: 38.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.24 > 1.0 |
| NWC/Revenue: 14.64% < 20% (prev 11.20%; Δ 3.44% < -1%) |
| CFO/TA 0.05 > 3% & CFO 38.0m > Net Income 38.4m |
| Net Debt (181.5m) to EBITDA (105.6m): 1.72 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.7m) vs 12m ago 2.01% < -2% |
| Gross Margin: 31.74% > 18% (prev 33.80%; Δ -2.06% > 0.5%) |
| Asset Turnover: 117.6% > 50% (prev 103.9%; Δ 13.70% > 0%) |
| Interest Coverage Ratio: 6.16 > 6 (EBIT TTM 60.1m / Interest Expense TTM 9.75m) |
| A: 0.17 (Total Current Assets 335.2m - Total Current Liabilities 207.7m) / Total Assets 756.0m |
| B: 0.12 (Retained Earnings 92.5m / Total Assets 756.0m) |
| C: 0.08 (EBIT TTM 60.1m / Avg Total Assets 739.8m) |
| D: 0.82 (Book Value of Equity 340.0m / Total Liabilities 416.0m) |
| Altman-Z'' = 2.91 = A |
| DSRI: 1.13 (Receivables 209.6m/160.1m, Revenue 870.3m/752.1m) |
| GMI: 1.06 (GM 33.80% / 31.74%) |
| AQI: 0.92 (AQ_t 0.45 / AQ_t-1 0.49) |
| SGI: 1.16 (Revenue 870.3m / 752.1m) |
| TATA: 0.00 (NI 38.4m - CFO 38.0m) / TA 756.0m) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of November 17, 2026, the stock is trading at CAD 85.55 with a total of 26,467 shares traded. Over the past week, the price has changed by +0.68%, over one month by +5.54%, over three months by -6.25% and over the past year by +65.26%.
Current recommended Stop Loss: 79.60 (which is 7% or 2.3 ATR below the current price).
Calian Technologies has no consensus analysts rating.
P/E Trailing = 27.0667
P/E Forward = 19.1205
P/S = 1.1826
P/B = 3.0285
Revenue TTM = 870.3m CAD
EBIT TTM = 60.1m CAD
EBITDA TTM = 105.6m CAD
Long Term Debt = 141.2m CAD (from longTermDebt, last quarter)
Short Term Debt = 6.20m CAD (from shortTermDebt, last quarter)
Debt = 227.8m CAD (from shortLongTermDebtTotal, last quarter) + Leases 43.3m
Net Debt = 181.5m CAD (calculated: Debt 227.8m - CCE 46.3m)
Enterprise Value = 1.21b CAD (1.03b + Debt 227.8m - CCE 46.3m)
Interest Coverage Ratio = 6.16 (Ebit TTM 60.1m / Interest Expense TTM 9.75m)
EV/FCF = 45.97x (Enterprise Value 1.21b / FCF TTM 26.3m)
FCF Yield = 2.18% (FCF TTM 26.3m / Enterprise Value 1.21b)
FCF Margin = 3.03% (FCF TTM 26.3m / Revenue TTM 870.3m)
Net Margin = 4.41% (Net Income TTM 38.4m / Revenue TTM 870.3m)
Gross Margin = 31.74% ((Revenue TTM 870.3m - Cost of Revenue TTM 594.0m) / Revenue TTM)
Gross Margin QoQ = 29.15% (prev 30.26%)
Tobins Q-Ratio = 1.60 (Enterprise Value 1.21b / Total Assets 756.0m)
Interest Expense / Debt = 4.28% (Interest Expense 9.75m / Debt 227.8m)
Taxrate = 21.00% (10.2m / 48.6m)
NOPAT = 47.5m (EBIT 60.1m * (1 - 21.00%))
Current Ratio = 1.61 (Total Current Assets 335.2m / Total Current Liabilities 207.7m)
Debt / Equity = 0.67 (Debt 227.8m / totalStockholderEquity, last quarter 340.0m)
Debt / EBITDA = 1.72 (Net Debt 181.5m / EBITDA 105.6m)
Debt / FCF = 6.89 (Net Debt 181.5m / FCF TTM 26.3m)
Total Stockholder Equity = 328.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.19% (Net Income 38.4m / Total Assets 756.0m)
RoE = 11.67% (Net Income TTM 38.4m / Total Stockholder Equity 328.9m)
RoCE = 12.79% (EBIT 60.1m / Capital Employed (Equity 328.9m + L.T.Debt 141.2m))
RoIC = 9.29% (NOPAT 47.5m / Invested Capital 511.0m)
WACC = 6.31% (E(1.03b)/V(1.26b) * Re(6.96%) + D(227.8m)/V(1.26b) * Rd(4.28%) * (1-Tc(0.21)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.33 | Cagr: -1.22%
[DCF] Terminal Value 73.10% ; FCFF base≈35.3m ; Y1≈30.9m ; Y5≈25.0m
[DCF] Fair Price = 19.06 (EV 401.1m - Net Debt 181.5m = Equity 219.6m / Shares 11.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 58.36 | EPS CAGR: 6.09% | SUE: 0.88 | # QB: 2
Revenue Correlation: 94.67 | Revenue CAGR: 8.24% | SUE: 1.63 | # QB: 2
EPS current Quarter (2026-12-31): EPS=1.02 | Chg30d=+1.59% | Revisions=+0% | Analysts=4
EPS current Year (2026-09-30): EPS=4.26 | Chg30d=+0.36% | Revisions=+0% | GrowthEPS=+29.7% | GrowthRev=+14.4%
EPS next Year (2027-09-30): EPS=4.77 | Chg30d=-1.00% | Revisions=+29% | GrowthEPS=+12.0% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: +29% (up=3, down=1)